Disc Medicine (IRON) Competitors $54.33 -1.85 (-3.29%) Closing price 04:00 PM EasternExtended Trading$54.30 -0.02 (-0.05%) As of 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IRON vs. AXSM, BPMC, CYTK, NUVL, ELAN, LNTH, KRYS, VRNA, GRFS, and TGTXShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Axsome Therapeutics (AXSM), Blueprint Medicines (BPMC), Cytokinetics (CYTK), Nuvalent (NUVL), Elanco Animal Health (ELAN), Lantheus (LNTH), Krystal Biotech (KRYS), Verona Pharma (VRNA), Grifols (GRFS), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. Disc Medicine vs. Axsome Therapeutics Blueprint Medicines Cytokinetics Nuvalent Elanco Animal Health Lantheus Krystal Biotech Verona Pharma Grifols TG Therapeutics Axsome Therapeutics (NASDAQ:AXSM) and Disc Medicine (NASDAQ:IRON) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends. Which has more risk and volatility, AXSM or IRON? Axsome Therapeutics has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, Disc Medicine has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Do analysts prefer AXSM or IRON? Axsome Therapeutics currently has a consensus price target of $167.36, suggesting a potential upside of 29.63%. Disc Medicine has a consensus price target of $89.10, suggesting a potential upside of 60.15%. Given Disc Medicine's stronger consensus rating and higher probable upside, analysts plainly believe Disc Medicine is more favorable than Axsome Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Which has better earnings & valuation, AXSM or IRON? Disc Medicine has lower revenue, but higher earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Disc Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxsome Therapeutics$385.69M16.32-$287.22M-$5.99-21.55Disc MedicineN/AN/A-$76.43M-$3.99-13.94 Does the MarketBeat Community believe in AXSM or IRON? Axsome Therapeutics received 417 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 86.15% of users gave Disc Medicine an outperform vote while only 70.28% of users gave Axsome Therapeutics an outperform vote. CompanyUnderperformOutperformAxsome TherapeuticsOutperform Votes47370.28% Underperform Votes20029.72% Disc MedicineOutperform Votes5686.15% Underperform Votes913.85% Is AXSM or IRON more profitable? Disc Medicine has a net margin of 0.00% compared to Axsome Therapeutics' net margin of -74.47%. Disc Medicine's return on equity of -25.24% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Axsome Therapeutics-74.47% -223.51% -39.88% Disc Medicine N/A -25.24%-23.96% Do institutionals & insiders have more ownership in AXSM or IRON? 81.5% of Axsome Therapeutics shares are held by institutional investors. Comparatively, 83.7% of Disc Medicine shares are held by institutional investors. 22.4% of Axsome Therapeutics shares are held by insiders. Comparatively, 4.2% of Disc Medicine shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor AXSM or IRON? In the previous week, Axsome Therapeutics had 9 more articles in the media than Disc Medicine. MarketBeat recorded 26 mentions for Axsome Therapeutics and 17 mentions for Disc Medicine. Disc Medicine's average media sentiment score of 0.83 beat Axsome Therapeutics' score of 0.27 indicating that Disc Medicine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Axsome Therapeutics 4 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Disc Medicine 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDisc Medicine beats Axsome Therapeutics on 12 of the 18 factors compared between the two stocks. Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65B$7.23B$5.84B$8.58BDividend YieldN/A2.79%4.75%3.98%P/E Ratio-13.916.2425.2119.52Price / SalesN/A198.22381.73112.26Price / CashN/A65.6738.0534.58Price / Book3.936.567.404.40Net Income-$76.43M$139.24M$3.19B$247.12M7 Day Performance1.82%-2.70%-2.59%-2.12%1 Month Performance1.17%-6.00%-4.28%-3.50%1 Year Performance-26.14%-12.55%13.31%6.23% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine2.9937 of 5 stars$54.33-3.3%$89.10+64.0%-25.4%$1.62BN/A-13.6530Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageAXSMAxsome Therapeutics4.7466 of 5 stars$130.72-5.1%$158.79+21.5%+54.7%$6.37B$385.69M-21.82380Analyst ForecastBPMCBlueprint Medicines2.8663 of 5 stars$92.48+0.2%$123.83+33.9%+1.5%$5.91B$508.82M-85.63640Analyst ForecastCYTKCytokinetics3.9743 of 5 stars$48.14-4.2%$82.00+70.3%-37.8%$5.68B$7.53M-8.95250Earnings ReportAnalyst ForecastAnalyst RevisionNUVLNuvalent2.1402 of 5 stars$78.03-1.8%$113.10+44.9%-14.0%$5.54BN/A-22.4940Earnings ReportAnalyst ForecastELANElanco Animal Health3.6566 of 5 stars$11.14+1.0%$16.00+43.7%-30.2%$5.50B$4.42B27.849,300Earnings ReportAnalyst RevisionLNTHLantheus4.51 of 5 stars$78.95+0.9%$131.86+67.0%+45.1%$5.49B$1.50B13.14700Earnings ReportKRYSKrystal Biotech4.2778 of 5 stars$186.89-0.5%$210.00+12.4%+6.8%$5.38B$290.52M62.51210Earnings ReportAnalyst ForecastInsider TradePositive NewsVRNAVerona Pharma2.3444 of 5 stars$65.60-3.5%$57.14-12.9%+282.8%$5.37B$460,000.00-34.1730Analyst ForecastAnalyst RevisionNews CoverageGRFSGrifols3.3617 of 5 stars$7.43-0.3%N/A+19.5%$5.11B$7.01B6.3523,737TGTXTG Therapeutics3.9661 of 5 stars$29.02-6.0%$40.67+40.1%+67.5%$4.52B$264.79M-290.17290Earnings ReportOptions VolumeNews Coverage Related Companies and Tools Related Companies Axsome Therapeutics Alternatives Blueprint Medicines Alternatives Cytokinetics Alternatives Nuvalent Alternatives Elanco Animal Health Alternatives Lantheus Alternatives Krystal Biotech Alternatives Verona Pharma Alternatives Grifols Alternatives TG Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRON) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRON Stock Alerts